Follow us on Twitter
This page is updated frequently with new Chloroform-related patents. Subscribe to the Chloroform RSS feed to automatically get the update: related Chloroform RSS feeds.
Subscribe to updates on this page: Chloroform RSS
|| List of recent Chloroform-related patents
|Automotive lamp extension molding|
[solution] the automotive lamp extension molding according to the present invention comprises a resin composition comprising 50 to 95 mass % of a polyphenylene ether (a), and having a specific gravity in the range of 1.00 to 1.12. The reduced viscosity (measured at 30° c.
|Toner, image forming method, and process cartridge|
A toner including a crystalline polyester resin (a), an amorphous resin (b), and a composite resin (c) having a condensation polymerization resin unit and an addition polymerization resin unit is provided. A molecular weight distribution of the toner based on thf-soluble contents thereof has a main peak within a molecular weight range from 1,000 to 10,000 and a half bandwidth of the main peak is 15,000 or less.
|Toner for forming image, image forming method, and image forming apparatus|
A toner, including: crystalline resin; non-crystalline resin; and a composite resin, wherein the crystalline resin is crystalline polyester resin (a), the non-crystalline resin comprises: non-crystalline resin (b) containing chloroform insoluble matter; and non-crystalline resin (c) having a softening temperature (t½) lower than that of the non-crystalline resin (b) by 25° c. Or more, an absolute value .
|Sulfur-modified chloroprene rubber, molding thereof, and production method therefore|
A sulfur-modified chloroprene rubber modified at the polymer terminals with at least one compound selected from tetramethylthiuram disulfide, tetraalkylthiuram disulfides with alkyl groups having a carbon number of 2 to 7 and dialkyldithiocarbamic acid salts with alkyl groups having a carbon number of 1 to 7, wherein there are peak tops at 3.55 to 3.61 ppm and at 3.41 to 3.47 ppm in 1h-nmr spectrum, as determined in deuterochloroform solvent, wherein the ratio (a/b) of the peak area (a) at 3.55 to 3.61 ppm to the peak area (b) at 4.2 to 6.5 ppm is 0.05/100 to 0.50/100, and the extract with ethanol/toluene azeotropic mixture, as specified by jis k 6229, is 3.0 to 9.0 mass %.. .
|Composition for treating influenza a (h1n1) virus and a preparation method therefor|
New pharmaceutical compositions extracted from ferula assa-foetida are confirmed to effectively treat influenza a (h1n1) virus. The extraction method of the new pharmaceutical compositions mainly includes steps of: (a) extracting f.
|Toner, image forming apparatus, image forming method, and process cartridge|
A toner, including: a binder resin; and a colorant, wherein the binder resin contains: a crystalline polyester resin (a); a non-crystalline resin (b); and a composite resin (c), where the composite resin (c) contains a condensation polymerization resin unit and an addition polymerization resin unit, wherein the toner contains chloroform insoluble matter in an amount of 1% by mass to 30% by mass, wherein the toner has a molecular weight distribution having a main peak in a range of 1,000 to 10,000 and a half width of 15,000 or less, where the molecular weight distribution is obtained through gel permeation chromatography (gpc) of tetrahydrofuran soluble matter of the toner, and wherein the toner has an endothermic peak in a range of 90° c. To 130° c.
|Thermoformable copolyester laminate|
A laminate includes the following substantially coextensive layers in the following order: (a) a non-sealable, self-supporting, thermoformable copolyester film layer having a first surface and a second surface, the second surface constituting an outermost, exposed surface of the laminate; (b) a laminating adhesive layer on the first surface of the thermoformable copolyester film layer; and (c) a self-supporting, thermoformable structural film layer having a first surface and a second surface, the first surface contacting the laminating adhesive layer. Polyethylene terephthalate constitutes at least 80% by weight of the self-supporting thermoformable copolyester film layer; the thermoformable structural film layer includes a polymer selected from the group consisting of polyamides, polypropylene, polyethylene, polyethylene terephthalate, ionomers, ethylene acrylic acid copolymers, ethylene vinyl acetate copolymers, polystyrene, ethylene vinyl alcohol copolymers and polyvinylidene chloride; the thermoformable copolyester film layer, the structural film layer and the laminate each shrink less than 5% in length and width upon exposure to boiling water for five seconds; and the laminate is thermoformable and its chloroform-soluble extractives meet the requirements of paragraph h(1) of 21 cfr §177.1630 as defined herein..
|Processed soybean material and method for producing processed soybean material|
The present inventors found that the natural flavor intrinsic to soybean is retained more than ever before when soybean is processed to prepare a processed soybean material having a specific lipid content, a dietary fiber content, an acid-soluble component content and a protein content, whereby the present problems were solved. More specifically, the processed soybean material of the present invention is such that, on a solid weight basis, (1) a content of lipid, extracted with a mixed organic solvent wherein a ratio of chloroform to methanol is 2:1, is 10 to 40% by weight, (2) a dietary fiber content is 5 to 40% by weight, (3) a potassium content is 1% by weight or less, (4) a protein content is 30 to 65% by weight, and (5) a sum of γ-conglycinin and 24 kda protein is 2.4 times or less of lipoxygenase protein in soybean proteins..
|Process for the preparation of efavirenz|
As a free base or a salt thereof, with diphosgene (tcmcf, trichloromethylchloroformate) cl3co—cocl in an organic solvent or in a biphasic medium comprised of an organic solvent and water, preferably but not mandatorily in the presence of a weak base in an amount sufficient to neutralize the reaction mixture or in an up to 30% molar excess of such amount.. .
|Copper (i) complexes for optoelectronic devices|
The invention relates to neutral mononuclear copper (i) complexes for emitting light and with a structure according to formula (a) in which: m represents: cu(i); l∩l represents: a single, negatively charged, bidentate ligand; n∩n represents: a diimine ligand (substituted with r and fg), in particular a substituted 2,2′-bipyridine derivative (bpy) or a substituted 1,10-phenanthroline derivative (phen); r represents: at least one sterically demanding substituent for preventing the planarisation of the complex in the excited state; fg=functional group, and represents: at least one second substituent for increasing solubility in organic solvents. The substituent can also be used for electron transport or alternatively for hole transport, said functional group being bound to the diimine ligands either directly or by means of suitable bridges; and the copper (i) complex: having a Δe(s1−t1) value of less than 2500 cm−1 between the lowest excited singlet state (s1) and the triplet state (t1) which lies below; having an emission lifespan of at most 20 μs; having an emission quantum yield of greater than 40%, and a solubility of at least 1 g/l in organic solvents, in particular polar organic hydrocarbons such as acetone, methyl ethyl ketone, benzene, toluene, chlorobenzene, dichlorobenzene, dichloromethane, chloroform, dichloroethane, tetrachloroethylene, alcohols, acetonitrile or water..
|Levocarrimycin, pharmaceutical compositions, preparation methods and uses thereof|
The present invention relates to levocarrimycin, its pharmaceutical compositions, preparation methods and application. Levocarrimycin is a mixture of isovalerylspiramycin iii, ii and i as main components and contains some isobutyrylspiramycin iii and ii, butyrylspiramycin iii and ii, propionylspiramycin iii and ii, as well as acetylspiramycin iii and ii, among which, the content of isovalerylspiramycin iii is no less than 30 wt %, the total content of isovalerylspiramycin iii, ii and i is no less than 60 wt %, and the content of acylspiramycin is 80-98 wt %.
The present invention provides a process for the preparation of pd2(dba)3.chcl3 comprising the steps of: (a) reacting a pd(ii) complex with an alkali metal halide in at least one alcohol solvent; and (b) reacting the product of step (a) with a mixture comprising dibenzylideneacetone, chloroform and an inorganic base to form pd2(dba)3.chcl3.. .
|Fat-reduced soybean protein material and soybean emulsion composition, and processes for production thereof|
Disclosed are: a fat-reduced soymilk having a reduced fat content, which is produced by separating a fat from a fat-containing soybean efficiently without relying on an organic solvent; and a novel fat-rich soybean material. Specifically disclosed are: a fat-reduced soybean protein material characterized by containing a protein and a carbohydrate at a total content of 80 wt % or more in terms of dried form content, containing a fat (as an extract from a chloroform/methanol mixed solvent) at a content of less than 10 wt % relative to the content of the protein, and containing campesterol and stigmasterol (as plant-derived sterols) at a total content of 200 mg or more relative to 100 g of a fat; and a soybean emulsion composition characterized by containing a protein at a content of 25 wt % or more in terms of dried form content, containing a fat at a content of 100 wt % or more in terms of dried form content relative to the content of the protein in terms of dried form content, and having an lci value of 60% or more..
|Method for producing bischloroformate compound, polycarbonate oligomer having small number of monomers and solution containing bischloroformate compound|
In the formulae (1) and (2), ar is a divalent aromatic group.. .
|Process to extract quassinoids|
A means for the extraction and crystallization of quassinoids such as quassin and neoquassin from natural sources containing these compounds, using compounds that are generally recognized as safe by the u.s. Food and drug administration is provided.
Popular terms: [SEARCH]
Chloroform topics: Chloroform, Chromatograph, Crystallin, Condensation, Addition Polymer, Chromatography, Automotive, Fourier Transform Infrared, Attenuation, Fourier Transform, Thermostat, Endothermic, Chloroprene, Alkyl Group, Terephthalate
Follow us on Twitter
This listing is a sample listing of patents related to Chloroform for is only meant as a recent sample of applications filed, not a comprehensive history. There may be associated servicemarks and trademarks related to these patents. Please check with patent attorney if you need further assistance or plan to use for business purposes. This patent data is also published to the public by the USPTO and available for free on their website. Note that there may be alternative spellings for Chloroform with additional patents listed. Browse our RSS directory or Search for other possible listings.